Dublin, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global IVF Market: Focus on Procedures, Instruments, and Reagents & Media - Analysis & Forecast, 2016-2022" report to their offering.

The global market is expected to grow over $26.08 billion by 2022

The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. IVF Market can be further divided into various segments and sub-segments.

The IVF procedure market has been divided into four main categories viz. Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Zygote Intrafallopian transfer (ZIFT) and Gamete Intrafallopian Transfer (GIFT) among others. Globally ICSI is the most frequently used technology, and currently accounts for two-third of the world's IVF market. Market share of ICSI is expected to decline in the future due to increasing investments in Frozen Embryo Replacement (FER) which is preferred by various end users like armed forces personnel and High Net worth Individual (HNI) among others.

Due to their limited applications, ZIFT and GIFT procedures reserve a small market share. These procedures are used only in special cases where the first IVF cycle is unsuccessful or the mother is facing serious issues in conceiving. Both these procedures are invasive, and thus, are less preferred in developed countries.

European countries prefer IVF treatments and egg donations, especially Spain which has highest number of egg donors, followed by Poland and Ukraine. In countries like the U.S., the U.K., Spain, France, and Denmark, the donor number has doubled in a span of 10 to 15 years. Moreover, the availability of skilled personnel, high quality of treatments at economical prices, and increasing awareness of IVF treatments are some of the major factors that are contributing to the growth of the European IVF market.

The increasing infertility cases, advancement of technologies, government support & regulations, educational awareness programs, and emerging reimbursement policies are some of the major factors driving the growth trajectory of this market. The development of pre-implantation diagnosis tests are helping parents to know about the well being of their baby in early stages of pregnancy and hence are foreseen as a viable opportunity for this market.

Key Topics Covered:

Executive Summary

1 Research Scope and Methodology

2 Introduction to IVF Market

3 Market Dynamics

4 Competitive Insights

5 Industry Analysis

6 Global IVF Market, Analysis & Forecast

7 Key Company Profiles

  • Abbott Laboratories
  • Affymetrix, Inc.
  • BioMérieux SA
  • Cepheid Inc.
  • CombiMatrix
  • GE Healthcare
  • Genea Biomedx
  • Illumina Inc.
  • Irvine Scientific
  • LabCorp Of America
  • OvaScience
  • Qiagen, Inc.
  • Quest Diagnostics
  • Roche Holding
  • Thermo Fisher Scientific
  • VitroLife

For more information about this report visit http://www.researchandmarkets.com/research/ppwpdb/global_ivf

CONTACT: Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health